Literature DB >> 22239580

Cingulate volume abnormalities in emerging psychosis.

Michel Röthlisberger1, Anita Riecher-Rössler, Jacqueline Aston, Paolo Fusar-Poli, Ernst-Wilhelm Radü, Stefan Borgwardt.   

Abstract

BACKGROUND: Neuroanatomical abnormalities, including cingulate cortex volume abnormalities, are a common feature in psychosis. However, the extent to which these are related to a vulnerability to psychosis, as opposed to the disorder per se, is less certain. AIM UND HYPOTHESES: The aim of the present study is to compare cingulate gray matter volumes in different stages of psychosis. We reviewed previous studies of subjects in a prodromal stage of psychosis and tested cingulate volume changes during the transition to psychosis.
METHODS: A cross-sectional MRI study of manually traced cingulate gray-matter volumes in 37 individuals with an at risk mental state (ARMS) for psychosis, 23 individuals with a first-episode psychosis (FEP), and 22 healthy controls (HC) was performed using a 1.5 T MRI-scanner. 16 of 37 ARMS individuals (43 %) developed psychosis during follow up (ARMS-T), whereas 21 did not (ARMS-NT). The mean duration of follow up in ARMS was 25.1 months. 8 cingulate subregions were analysed in a region-of-interest analysis.
RESULTS: Compared to HC, subjects with an ARMS had significantly reduced left caudal anterior cingulate cortex volume (p < 0.027). This finding was also evident at a trend level (p: 0.069) in FEP patients. Within ARMS, the ARMS-T group showed a significantly reduced whole right cingulate cortex (p: 0.036), right subgenual cingulate cortex (p: 0.036) and right posterior cingulate cortex (p: 0.012) compared to ARMS-NT. DISCUSSION: These results suggest that the at risk mental state is associated with cingulate volume reductions, in particular in the left caudal anterior cingulate cortex (CACC). These abnormalities do not only seem to occur with transition to psychosis, but may be a correlate of an increased vulnerability to psychosis.

Entities:  

Mesh:

Year:  2012        PMID: 22239580     DOI: 10.2174/138161212799316316

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

1.  Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia.

Authors:  Alice Egerton; Stefan Brugger; Marie Raffin; Gareth J Barker; David J Lythgoe; Philip K McGuire; James M Stone
Journal:  Neuropsychopharmacology       Date:  2012-07-04       Impact factor: 7.853

Review 2.  Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.

Authors:  Trevor Archer; Serafino Ricci; Danilo Garcia; Max Rapp Ricciardi
Journal:  Neurotox Res       Date:  2014-05-08       Impact factor: 3.911

3.  Functional brain networks before the onset of psychosis: A prospective fMRI study with graph theoretical analysis.

Authors:  Louis-David Lord; Paul Allen; Paul Expert; Oliver Howes; Matthew Broome; Renaud Lambiotte; Paolo Fusar-Poli; Isabel Valli; Philip McGuire; Federico E Turkheimer
Journal:  Neuroimage Clin       Date:  2012-09-23       Impact factor: 4.881

Review 4.  Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells.

Authors:  Samuel K Powell; Callan P O'Shea; Sara Rose Shannon; Schahram Akbarian; Kristen J Brennand
Journal:  Adv Neurobiol       Date:  2020

5.  Reduced parahippocampal cortical thickness in subjects at ultra-high risk for psychosis.

Authors:  S Tognin; A Riecher-Rössler; E M Meisenzahl; S J Wood; C Hutton; S J Borgwardt; N Koutsouleris; A R Yung; P Allen; L J Phillips; P D McGorry; I Valli; D Velakoulis; B Nelson; J Woolley; C Pantelis; P McGuire; A Mechelli
Journal:  Psychol Med       Date:  2013-05-10       Impact factor: 7.723

6.  Schizophrenia-risk variant rs6994992 in the neuregulin-1 gene on brain developmental trajectories in typically developing children.

Authors:  V Douet; L Chang; A Pritchett; K Lee; B Keating; H Bartsch; T L Jernigan; A Dale; N Akshoomoff; S Murray; C Bloss; D N Kennedy; D Amaral; J Gruen; W E Kaufmann; B J Casey; E Sowell; T Ernst
Journal:  Transl Psychiatry       Date:  2014-05-27       Impact factor: 6.222

7.  The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis.

Authors:  Stefania Tognin; Anja Richter; Matthew J Kempton; Gemma Modinos; Mathilde Antoniades; Matilda Azis; Paul Allen; Matthijs G Bossong; Jesus Perez; Christos Pantelis; Barnaby Nelson; Paul Amminger; Anita Riecher-Rössler; Neus Barrantes-Vidal; Marie-Odile Krebs; Birte Glenthøj; Stephan Ruhrmann; Gabriele Sachs; Bart P F Rutten; Lieuwe de Haan; Mark van der Gaag; Lucia R Valmaggia; Philip McGuire
Journal:  Schizophr Bull Open       Date:  2022-06-20

8.  Using structural neuroimaging to make quantitative predictions of symptom progression in individuals at ultra-high risk for psychosis.

Authors:  Stefania Tognin; William Pettersson-Yeo; Isabel Valli; Chloe Hutton; James Woolley; Paul Allen; Philip McGuire; Andrea Mechelli
Journal:  Front Psychiatry       Date:  2014-01-29       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.